Neoadjuvant STING Activation, Extended Half-life IL2, and Checkpoint Blockade Promote Metastasis Clearance via Sustained NK-cell Activation

Neoadjuvant STING Activation, Extended Half-life IL2, and Checkpoint Blockade Promote Metastasis Clearance via Sustained NK-cell Activation

<jats:title>Abstract</jats:title> <jats:sec> <jats:title /> <jats:p>Combination immunotherapy treatments that recruit both innate and adaptive immunity have the potential to increase cancer response rates by engaging...

Full description

Bibliographic Details
Main Authors: Milling, Lauren E, Garafola, Daniel, Agarwal, Yash, Wu, Shengwei, Thomas, Ayush, Donahue, Nathan, Adams, Josetta, Thai, Nikki, Suh, Heikyung, Irvine, Darrell J
Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering
Format: Article
Language:English
Published: American Association for Cancer Research (AACR) 2023
Online Access:https://hdl.handle.net/1721.1/147839

Internet

https://hdl.handle.net/1721.1/147839

Similar Items